ArticleJournal of advanced veterinary and animal research2025
Jackfruit
Article in Journal of advanced veterinary and animal research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Diabetes mellitus and obesity stand as globally prevalent, life-threatening metabolic diseases. It has been reported that the intake of a high-sugar diet (HSD) increases the risk of developing diabetes and obesity. Therefore, it is necessary to find an alternative supplemental diet that could reduce the harmful consequences of excessive sugar consumption. The current study aimed to explore how jackfruit seed powder (JSP) could potentially prevent metabolic diseases in mice induced by an HSD. Materials and Methods: Swiss albino male mice were categorized into six groups fed normal and HSDs with or without JSP supplementation for 8 weeks. After the end of the feeding trial, different parameters related to glucose and lipid homeostasis were measured. Results: We found that 20% of JSP supplementation significantly decreased food intake and body weight gain induced by HSD. Supplementation of JSP reduced the liver weight, white adipose tissue, and brown adipose tissue weight in HSD-fed mice. Moreover, the addition of JSP with HSD improved the glucose tolerance test and reduced the levels of total cholesterol, triglyceride, and low-density lipoprotein cholesterol. Conclusion: These findings indicate that adding 20% JSP is particularly efficient in averting the onset of metabolic diseases induced by an HSD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.